Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial - Saad, Fred; Hadaschik, Boris (The lancet. Oncology, 2018)
Gesehen am 07.05.2019